Description
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
| Cas No. | 950736-05-7 |
|---|---|
| Purity | ≥98% |
| Formula | C29H24F3N5O |
| Formula Wt. | 515.54 |
| IUPAC Name | N-[3-(3-{4-[(Dimethylamino)methyl]phenyl}pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-3-(trifluoromethyl)benzamide |
| Solubility | DMSO: ≥ 53 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Berger DM, Torres N, Dutia M, et al. Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6519-23. PMID: 19864136.
Oltipraz analog, salivary gland secretion enhan...
Peptide, protease substrate.
β-adrenergic antagonist, voltage-gated Na+ and...
Inhibitor of ALK2, ALK3, ALK6, and AMPK.
Antimicrobial peptide found in frogs, induces p...
p110γ PI3K inhibitor, potential TRPC1/5/6 nega...
Dual mTORC1/mTORC2 inhibitor.
Thrombin inhibitor.
NSAID; COX-1/2 inhibitor.
Pt-based DNA cross-linker.
Selective inhibitor of PI3Kβ and PI3Kδ.
Ca2+-sensing receptor agonist.
Form of vitamin C found in various plant and fo...
5-HT2A antagonist, potential α1-adrenergic ant...
Folate source co-administered with methotrexate...
DP1 antagonist.
mTOR inhibitor.
Inhibits HCV replication
Phenylethylamine; β2-adrenergic agonist, SK/BK...
p110α and p110γ PI3K inhibitor.